Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
about
Targeting gastrointestinal stromal tumors: the role of regorafenibMyxoid epithelioid gastrointestinal stromal tumor harboring an unreported PDGFRA mutation: report of a case and review of the literatureReview article: the biology, diagnosis and management of gastrointestinal stromal tumoursA young man with primary prostatic extra-gastrointestinal stromal tumor: a rare case report and review of the literatureNovel uses of immunohistochemistry in the diagnosis and classification of soft tissue tumorsManagement of early asymptomatic gastrointestinal stromal tumors of the stomachDiscovered on gastrointestinal stromal tumours 1 (DOG1) expression in non-gastrointestinal stromal tumour (GIST) neoplasms.Clinical and molecular characteristics of gastrointestinal stromal tumors in the pediatric and young adult populationTherapeutic effect and mechanism of electroacupuncture at Zusanli on plasticity of interstitial cells of Cajal: a study of rat ileum.NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors.A CD117 and CD34 immunoreactive sarcoma masquerading as a gastrointestinal stromal tumor: diagnostic pitfalls of ancillary studies in sarcoma.Downsizing treatment with tyrosine kinase inhibitors in patients with advanced gastrointestinal stromal tumors improved resectability.Clinical practice guideline for accurate diagnosis and effective treatment of gastrointestinal stromal tumor in KoreaDefects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.Primary omental gastrointestinal stromal tumour (GIST) presenting with a large abdominal mass and spontaneous haemoperitoneum.GEIS 2013 guidelines for gastrointestinal sarcomas (GIST)Retrospective analysis of extra-gastrointestinal stromal tumors.Immunoreactivity for Ano1 detects depletion of Kit-positive interstitial cells of Cajal in patients with slow transit constipation.Expression of DOG1, PDGFRA, and p16 in Gastrointestinal Stromal TumorsBiomarkers and molecular diagnosis of gastrointestinal and pancreatic neoplasmsParallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations.Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors.Pathology of gastrointestinal stromal tumors.Diagnosis value of CD117 and PDGFRA, alone or in combination DOG1, as biomarkers for gastrointestinal stromal tumors.Histopathological Features of Gastrointestinal Stromal Tumors and the Contribution of DOG1 Expression to the Diagnosis.Profile of patients with gastrointestinal stromal tumors (GIST)Extended adjuvant therapy with imatinib in patients with gastrointestinal stromal tumors : recommendations for patient selection, risk assessment, and molecular response monitoring.The KIT Exon 11 Stop Codon Mutation in Gastrointestinal Stromal Tumors: What Is the Clinical Meaning?Gastrointestinal Stromal Tumor Mimicking as Ovarian Tumor in Gynaecologic OncologySurgical treatment of gastric gastrointestinal stromal tumorDOG1 regulates growth and IGFBP5 in gastrointestinal stromal tumors.Multiple Gastric Gastrointestinal Stromal Tumors in a Patient with Neurofibromatosis Type 1Dedifferentiation in gastrointestinal stromal tumor to an anaplastic KIT-negative phenotype: a diagnostic pitfall: morphologic and molecular characterization of 8 cases occurring either de novo or after imatinib therapy.Imatinib treatment for gastrointestinal stromal tumour (GIST).Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor.Gastrointestinal stromal tumors associated with neurofibromatosis 1: a single centre experience and systematic review of the literature including 252 casesSEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016).Gastrointestinal stromal tumor and its mimics.Endoscopic ultrasound-guided fine-needle aspiration of intrathoracic and intra-abdominal spindle cell and mesenchymal lesions.The GIST paradigm: lessons for other kinase-driven cancers.
P2860
Q26747162-DD818BC8-8ABA-445F-8B5C-043ACAD47C1EQ26801942-F1D450F7-7EE7-4C67-B47E-DD918032DED5Q26825310-BB21A865-BABF-4D93-AB16-37B31EE61FC1Q26827469-DF741A90-FDF1-4ACE-AB0C-E79DADB674F9Q27001114-07B2DBFC-2DC5-4268-8C7B-04CA0DD3DC90Q30434738-5DED76CE-58C3-4DB4-B976-95FBDFF3B3ECQ33274455-8F39C244-AA70-490F-B300-C1EF3075D3A1Q33654872-81DFC4C5-2BFE-4864-BC98-E5ECF3EE63C8Q33895687-9425ADCF-19F2-4891-BAC9-BCB3B8E7C90EQ33921067-F65A9D87-110A-44F1-8229-CBFF9ECE7827Q33930442-B34AA9C5-F687-47E1-ACCF-21FBEE334D02Q34050275-EE0CBC6D-EB6B-437B-941B-781F079AFDCAQ34255550-2E4D2F49-C6AE-4797-AC7C-983C94300693Q34471702-5BEA3E4F-C4F9-4B11-81E3-050D3C119904Q34476909-4A5B5FFD-B014-45A0-B63F-6BC9D8A5FB7BQ34664305-37300ED7-0D25-45C6-9C9B-760FEB235D97Q35069483-A55A9CF2-AC74-49FD-9BB5-5AA8D759B017Q35112646-9A117ECA-FE7D-4D79-BE1C-95CC87AAB293Q35119141-E2B4FBB8-9456-40B5-9C74-D8B74242BE1AQ35399306-C8E0CBEF-D091-4AB4-BD5C-CAAE5C30FACCQ35921190-DB23EB43-8475-44F1-99C3-71935DD8D00FQ35988533-D00C5C25-14EC-432B-B1F3-CADAB2B73500Q36129663-CB6C57B5-09EB-402D-9591-DA531EE14FAAQ36345799-E60E5681-0396-4D58-801D-BC4AD1241AFBQ36407671-64BEF5C4-0A0B-4A1B-823B-C44E308EA92DQ36533239-C02EC31D-7514-40C9-8A0C-B1B206DFAB3EQ36589296-86064A5B-7757-4E6E-8ECF-1E5C2B709CC0Q36609547-3D42C8F9-A921-432E-8292-DD8479E9BB3FQ36739890-8ECB9ED5-3FBC-4ED1-9FD4-0CBFFF73CC8CQ36770203-B35329C8-3392-4DD2-B70B-9366358EAB4EQ36959577-D4C57BD6-5FF7-4F1C-852F-B4273CB21F01Q37023435-D291C438-2E54-4EDB-8517-2011FD1C545CQ37058556-C51CC8ED-1947-41BC-AD43-89682F267CF7Q37334993-833D6B52-7862-4246-8293-7B5C37757CC4Q37367438-6FDFE45B-916A-4120-AA27-1700BCC5C0E7Q37413027-1153C0EA-9572-4EEB-9CF6-06CE9D7D59BFQ37475154-430B83E2-1AC2-4EE4-868F-D31D6D1FAE1DQ37756377-3814A708-DC36-4E15-B45A-FA46FD5F0243Q37802310-AE7A44D6-B87E-4C4C-86EB-D7D559F6E3B3Q37815140-3AFF57C4-25DB-4485-97D3-9A511EB671ED
P2860
Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Monoclonal antibody DOG1.1 sho ...... s, including unusual subtypes.
@ast
Monoclonal antibody DOG1.1 sho ...... s, including unusual subtypes.
@en
Monoclonal antibody DOG1.1 sho ...... s, including unusual subtypes.
@nl
type
label
Monoclonal antibody DOG1.1 sho ...... s, including unusual subtypes.
@ast
Monoclonal antibody DOG1.1 sho ...... s, including unusual subtypes.
@en
Monoclonal antibody DOG1.1 sho ...... s, including unusual subtypes.
@nl
prefLabel
Monoclonal antibody DOG1.1 sho ...... s, including unusual subtypes.
@ast
Monoclonal antibody DOG1.1 sho ...... s, including unusual subtypes.
@en
Monoclonal antibody DOG1.1 sho ...... s, including unusual subtypes.
@nl
P2093
P1476
Monoclonal antibody DOG1.1 sho ...... s, including unusual subtypes.
@en
P2093
Bernadette Liegl
Christopher D M Fletcher
Christopher L Corless
P304
P356
10.1097/PAS.0B013E318186B158
P407
P577
2009-03-01T00:00:00Z